Abstract
Donor cell leukemia (DCL) is considered as a rare complication following allogeneic bone marrow transplantation (BMT), whereas the actual frequency of DCL has not yet been specified. Cord blood (CB) is now recognized as an alternative source for stem cell transplantation (SCT), with more than 6000 cord blood transplants (CBTs) performed worldwide, and a few cases of DCL following CBT have also been reported. Here we report four cases of DCL developed after unrelated CBTs using 490 shipped units from Tokyo cord blood bank (TCBB). Development of DCL was informed to TCBB by attending physicians of the recipients in CBT centers as soon as definite diagnosis was made. The feed-back from CBT centers on four DCL cases is summarized in Table 1. All the donors were well at the follow-up questionnaire 6–12 months after birth, but further information of their health conditions has not yet been obtained.Table 1Four cases of DCL following CBTCase1234Recipient32F32F56F30MDiseaseAML in REL1AML-M0 in REL1ATLHodgkin's diseaseSCT1st2nd2nd2ndRegimenMyeloablativeMyeloablativeNon-myeloablativeNon-myeloablativeTBI12Gy12Gy(−)2GyG-CSF(+)(+)(+)(+)GVHD prophylaxisCsA+sMTXCsA+sMTXFK506+PSLCsA+sMTXaGVHDIIII0IIIcGVHD(−)(−)(−)limitedDCLAMLAML-M2AMLAML-M5Latent period15 Mm after CBT11 Mm after CBT7 Mm after CBT16 Mm after CBTDiagnosisFISHSTRFISHSTRThe etiology of DCL is unclear and a common mechanism is unlikely according to the reported literature. There exist several possibilities including occult leukemia or preleukemic state in the donor, defect in immune surveillance, therapy-related stromal abnormalities, excess of cytokine stimulation, and DNA replication and/or repair errors associated with post-transplant expansion of stem/progenitor cells. The possibility of occult leukemia in the donor raises serious problems regarding to the ethical responsibilities of the CBB to the donor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.